Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Prostatic Neoplasms × X-Rays × Clear all

Status

Sponsor Class

Study Type

Interventional 19 Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3 Breast Neoplasms 3 Glioma 2 Vascular Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Thoracic Cancer 1 Prostatic Neoplasms 1 Nasopharyngeal Carcinoma 1 Myeloproliferative Disorders 1 MR-PET Imaging 1 Leukemia 1 Kidney Neoplasms 1 Infections 1 Hypertension, Pulmonary 1 Hip Fractures 1 Gastrostomy 1 Endometrial Neoplasms 1 Breast Cyst 1 Bone Cysts, Aneurysmal 1 Bone Cysts 1 Astrocytoma 1 Adenocarcinoma, Follicular 1

Interventions

Surveys and Questionnaires 29 Blood Specimen Collection 20 enzalutamide 15 Leuprolide 13 Docetaxel 13 Biopsy 13 Abiraterone Acetate 13 apalutamide 12 Radiotherapy 12 Interviews as Topic 11 Watchful Waiting 10 Observation 10 Magnetic Resonance Spectroscopy 10 radium Ra 223 dichloride 8 darolutamide 8 Androgen Antagonists 8 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7 Radiosurgery 7 Magnetic Resonance Imaging 7 abiraterone 6 Specimen Handling 6 Brachytherapy 6 Standard of Care 5 Positron Emission Tomography Computed Tomography 5 Focus Groups 5 Amplified Fragment Length Polymorphism Analysis 5 Registries 4 Radiotherapy, Intensity-Modulated 4 Hematologic Tests 4 Gonadotropin-Releasing Hormone 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01516866 2019-11-18

NaFl PET/CT

University of Wisconsin, Madison

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡